Therapeutic approaches in intermediate-stage hepatocellular carcinoma (HCC): a novel insight of adjuvant transarterial chemoembolization (TACE)

Chin Clin Oncol. 2023 Apr;12(2):11. doi: 10.21037/cco-23-21. Epub 2023 Mar 30.

Authors

Paula Fernández-Palanca¹, José L Mauriz¹

Affiliation

¹ Institute of Biomedicine (IBIOMED), Universidad de León, Campus de Vegazana s/n, León, Spain; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain.

PMID: 37038055
DOI: 10.21037/cco-23-21

No abstract available

Keywords: Hepatocellular carcinoma (HCC); lenvatinib; transarterial chemoembolization (TACE).

MeSH terms

Carcinoma, Hepatocellular* / pathology
Carcinoma, Hepatocellular* / therapy
Chemoembolization, Therapeutic*
Humans
Liver Neoplasms* / pathology
Liver Neoplasms* / therapy
Retrospective Studies
Treatment Outcome
Vascular Surgical Procedures